Associated Papers
CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors.
Jesus TT et al.
Npj Precision Oncology, 2025
41350422 (PubMed )
Supplement: 41698_2025_1210_MOESM1_ESM.pdf
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.
Chaubal R et al.
Breast Cancer Research and Treatment, 2025
40652157 (PubMed )
Supplement: 10549_2025_7759_MOESM5_ESM.xlsx › stable9
Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis.
Kim B et al.
Endocrinology and Metabolism (seoul, Korea), 2024
39552147 (PubMed )
Supplement: enm-2024-2008-Supplemental-Table-S1.pdf
First reported case of multiple endocrine neoplasia type 1 in an Australian Aboriginal.
Mignone E et al.
Endocrinology, Diabetes & Metabolism Case Reports, 2024
A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
Sakurai M et al.
Endocrine Journal, 2023
NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability.
Wang H et al.
Cancer Medicine, 2022
35506567 (PubMed )
Supplement: CAM4-11-2541-s004.pdf
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
Romanet P et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Gleeson FC et al.
Oncotarget, 2017
29212165 (PubMed )
Supplement: oncotarget-08-93464-s001.pdf
Oncocytic subtype of well differentiated neuroendocrine tumor: clinicopathologic and molecular associations of a cohort diagnosed on fine needle aspiration (FNA).
Hsiao WY et al.
Journal of the American Society of Cytopathology, 0
Select a paper to view details